Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Trypanosoma brucei | metallo- peptidase, Clan M- Family M48 | 0.0066 | 0.354 | 1 |
Mycobacterium ulcerans | aldehyde dehydrogenase | 0.006 | 0.3065 | 0.5 |
Brugia malayi | Calcitonin receptor-like protein seb-1 | 0.0049 | 0.2204 | 0.4833 |
Mycobacterium ulcerans | aldehyde dehydrogenase | 0.006 | 0.3065 | 0.5 |
Plasmodium falciparum | glutathione reductase | 0.0046 | 0.1937 | 0.5 |
Plasmodium vivax | glutathione reductase, putative | 0.0046 | 0.1937 | 0.5 |
Echinococcus granulosus | caax prenyl protease 1 | 0.0066 | 0.354 | 1 |
Entamoeba histolytica | CAAX prenyl protease, putative | 0.0066 | 0.354 | 0.5 |
Mycobacterium tuberculosis | Dihydrolipoamide dehydrogenase LpdC (lipoamide reductase (NADH)) (lipoyl dehydrogenase) (dihydrolipoyl dehydrogenase) (diaphoras | 0.0116 | 0.7593 | 1 |
Mycobacterium tuberculosis | Probable oxidoreductase | 0.0116 | 0.7593 | 1 |
Mycobacterium ulcerans | aldehyde dehydrogenase | 0.006 | 0.3065 | 0.5 |
Mycobacterium leprae | DIHYDROLIPOAMIDE DEHYDROGENASE LPD (LIPOAMIDE REDUCTASE (NADH)) (LIPOYL DEHYDROGENASE) (DIHYDROLIPOYL DEHYDROGENASE) (DIAPHORASE | 0.0116 | 0.7593 | 1 |
Mycobacterium tuberculosis | Probable aldehyde dehydrogenase | 0.006 | 0.3065 | 0.1994 |
Mycobacterium tuberculosis | Probable nitrite reductase [NAD(P)H] large subunit [FAD flavoprotein] NirB | 0.0104 | 0.6655 | 0.8342 |
Leishmania major | CAAX prenyl protease 1, putative,metallo-peptidase, Clan M-, Family M48 | 0.0066 | 0.354 | 1 |
Trichomonas vaginalis | Clan MA, family M48, Ste24 endopeptidase-like metallopeptidase | 0.0066 | 0.354 | 1 |
Mycobacterium tuberculosis | Probable membrane NADH dehydrogenase NdhA | 0.0104 | 0.6655 | 0.8342 |
Leishmania major | aldehyde dehydrogenase, mitochondrial precursor | 0.006 | 0.3065 | 0.7037 |
Loa Loa (eye worm) | thioredoxin reductase | 0.0046 | 0.1937 | 0.3801 |
Loa Loa (eye worm) | pigment dispersing factor receptor c | 0.0049 | 0.2204 | 0.4833 |
Brugia malayi | Corticotropin releasing factor receptor 2 precursor, putative | 0.0049 | 0.2204 | 0.4833 |
Plasmodium falciparum | thioredoxin reductase | 0.0046 | 0.1937 | 0.5 |
Loa Loa (eye worm) | peptidase family M48 containing protein | 0.0066 | 0.354 | 1 |
Loa Loa (eye worm) | glutathione reductase | 0.0046 | 0.1937 | 0.3801 |
Mycobacterium tuberculosis | Putative ferredoxin reductase | 0.0104 | 0.6655 | 0.8342 |
Plasmodium vivax | thioredoxin reductase, putative | 0.0046 | 0.1937 | 0.5 |
Brugia malayi | glutathione reductase | 0.0046 | 0.1937 | 0.3801 |
Loa Loa (eye worm) | hypothetical protein | 0.0049 | 0.2204 | 0.4833 |
Echinococcus multilocularis | caax prenyl protease 1 | 0.0066 | 0.354 | 1 |
Trypanosoma cruzi | CAAX prenyl protease 1, putative | 0.0066 | 0.354 | 1 |
Mycobacterium tuberculosis | NAD(P)H quinone reductase LpdA | 0.0116 | 0.7593 | 1 |
Brugia malayi | Thioredoxin reductase | 0.0046 | 0.1937 | 0.3801 |
Trypanosoma cruzi | metallo- peptidase, Clan M- Family M48 | 0.0066 | 0.354 | 1 |
Trichomonas vaginalis | Clan MA, family M48, Ste24 endopeptidase-like metallopeptidase | 0.0066 | 0.354 | 1 |
Brugia malayi | Peptidase family M48 containing protein | 0.0066 | 0.354 | 1 |
Echinococcus granulosus | aldehyde dehydrogenase mitochondrial | 0.006 | 0.3065 | 0.7037 |
Schistosoma mansoni | aldehyde dehydrogenase | 0.006 | 0.3065 | 0.2334 |
Schistosoma mansoni | aldehyde dehydrogenase | 0.006 | 0.3065 | 0.2334 |
Mycobacterium tuberculosis | Probable NADH dehydrogenase Ndh | 0.0104 | 0.6655 | 0.8342 |
Toxoplasma gondii | aldehyde dehydrogenase | 0.006 | 0.3065 | 0.7037 |
Schistosoma mansoni | farnesylated-protein converting enzyme 1 (M48 family) | 0.0066 | 0.354 | 0.2859 |
Mycobacterium tuberculosis | Probable dehydrogenase | 0.0104 | 0.6655 | 0.8342 |
Toxoplasma gondii | CAAX metallo endopeptidase | 0.0066 | 0.354 | 1 |
Echinococcus multilocularis | aldehyde dehydrogenase, mitochondrial | 0.006 | 0.3065 | 0.7037 |
Mycobacterium tuberculosis | Probable reductase | 0.0104 | 0.6655 | 0.8342 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.